Post-approval studies (Phase 4)UnknownNCT05660811
What this trial is testing
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
Who this might be right for
Atrial Fibrillation
National Institute of Cardiology, Warsaw, Poland 80